MedPath

The Effect of Antiemetics on Bowel Preparation Before Colonoscopy

Phase 4
Conditions
Bowel Preparation
Interventions
Registration Number
NCT04583111
Lead Sponsor
RenJi Hospital
Brief Summary

Polyethylene glycol (PEG) is one of the most common laxatives used in colonoscopy. However, 5 - 15% of patients can not complete the preparation due to its poor taste and large volume. So this study is aimed to explore the effect of antiemetics on abdominal discomforts associated with PEG.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
  • 18-70 years patients scheduled for colonoscopy
Exclusion Criteria
  • intestinal obstruction or hemorrhage;
  • allergy to domperidone, sulpiride or PEG;
  • pregnancy or breastfeeding;
  • previous use of prokinetics within 1 month.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Domperidone groupDomperidonePatients in Domperidone group took 10mg of domperidone 30min before PEG.
Sulpiride groupsulpiridePatients in Sulpiride group took 100mg of sulpiride 30min before PEG.
Primary Outcome Measures
NameTimeMethod
Incidence of the discomforts during bowel preparationbefore colonoscopy

The primary endpoint of this study was the discomforts during bowel preparation such as nausea, vomit, abdominal fullness and pain. These symptoms were assessed as none, mild, moderate and severe. Patients with mild to severe symptoms were classified as presence of discomforts.

Secondary Outcome Measures
NameTimeMethod
The quality of bowel preparation assessed by Boston Bowel Preparation Scaleduring colonoscopy

The secondary endpoint was the quality of bowel preparation assessed by the Boston Bowel Preparation Scale (BBPS) during the withdrawal phase of colonoscopy. The BBPS uses a 0-3 points scale assessing the bowel preparation quality in 3 segments of the colon (the right, transverse and left colons). BBPS score ≥ 6 were defined as adequate bowel preparation.

Trial Locations

Locations (1)

Shengliang Chen

🇨🇳

Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath